Kuizenga-Wessel Sophie, Heckert Sascha L, Tros Willemijn, van Etten-Jamaludin Faridi S, Benninga Marc A, Tabbers Merit M
*Department of Pediatric Gastroenterology and Nutrition, Emma Children's Hospital, Academic Medical Center †Medical library, Academic Medical Centre, Amsterdam, The Netherlands.
J Pediatr Gastroenterol Nutr. 2016 Jun;62(6):840-6. doi: 10.1097/MPG.0000000000001110.
Standardized outcome measures provide a basis for comparing outcomes of different clinical trials. Consequently, they can serve as the foundation for determining which therapeutic interventions are most effective. The aim of the present study is to systematically assess how definitions and outcome measures are defined in therapeutic randomized controlled trials (RCTs) of children with functional constipation (FC).
PubMed, EMBASE, and Cochrane databases were searched. Studies were included if it was a (systematic review of) therapeutic RCT, concerning children from 1 to 18 years old with FC, a definition of FC was provided, and if they were written in English. The Delphi list was used for quality assessment.
A total of 4092 articles were found but only 45 studies fulfilled our inclusion criteria. In these 45 trials, 22 different definitions of FC were used (17 studies used the Rome III-criteria), 27 different interventions were investigated, and 29 different definitions of treatment success were used. Thirty RCTs (57%) reported primary outcomes of which treatment success was the most frequently used. Most trials (80%) used parental diaries of which only 2 RCTs stated that their instrument was validated. Twenty-four trials (53%) were of good methodological quality.
Inconsistency and heterogeneity exist in definitions and outcome measures used in RCTs on childhood FC. Standard definitions, outcome measures, and also validated instruments are needed. We recommend the development of a minimum core outcome set for clinical research in children with FC to make comparison possible between the effects of different therapeutic interventions across studies.
标准化的结局指标为比较不同临床试验的结果提供了基础。因此,它们可作为确定哪些治疗干预措施最有效的依据。本研究的目的是系统评估在功能性便秘(FC)儿童的治疗性随机对照试验(RCT)中,定义和结局指标是如何界定的。
检索了PubMed、EMBASE和Cochrane数据库。纳入的研究需为关于1至18岁FC儿童的治疗性RCT(或其系统评价),提供了FC的定义,且为英文撰写。采用德尔菲列表进行质量评估。
共检索到4092篇文章,但只有45项研究符合我们的纳入标准。在这45项试验中,使用了22种不同的FC定义(17项研究使用了罗马Ⅲ标准),研究了27种不同的干预措施,使用了29种不同的治疗成功定义。30项RCT(57%)报告了主要结局,其中治疗成功是最常用的。大多数试验(80%)使用了家长日记,其中只有2项RCT表明其工具经过了验证。24项试验(53%)具有良好的方法学质量。
儿童FC的RCT中使用的定义和结局指标存在不一致性和异质性。需要标准的定义、结局指标以及经过验证的工具。我们建议为FC儿童的临床研究制定一个最小核心结局集,以便能够比较不同研究中不同治疗干预措施的效果。